Penumbra, Inc. PEN
321.46 USD -0.39 (-0.12%)
At closeNov 11, 2026, 4:28 AM EST
321.51 +0.05 +0.02%
Pre-market · Nov 11, 4:28 AM ET
320.21 Day range 321.60
271.32 52-week range 362.41
- YTD
- +3.39%
- 1 year
- +18.82%
News
benzinga.com Penumbra Q3 EPS $1.07 Misses $1.25 Estimate, Sales $410.145M Beat $403.345M Estimate Penumbra (NYSE:PEN) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.25 by 14.4 percent. This is a 10.31 percent increase over earnings of $0.97 per…
benzinga.com Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and…